Stada Arzneimittel AG
Type | Aktiengesellschaft
Traded as | FWB: SAZ
Industry | Pharmaceuticals
Founded | Dresden, 1895
Headquarters | Bad Vilbel , Germany
Key people | Peter Goldschmidt CEO Günter von Au (Chairman of the supervisory board)
Products | Generic and over-the-counter drugs
Revenue | €2.33 billion (2018)
Operating income | €378.1 million (2018)
Net income | €306.9 million (2018)
Total assets | €3.335 billion (end 2014)
Total equity | €903.3 million (end 2014)
Number of employees | 10,416 (FTE, average 2018)
Website | www.stada.com